{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:55:34Z","timestamp":1792688134737,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4560,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.fertnstert.2009.06.033","type":"journal-article","created":{"date-parts":[[2009,7,26]],"date-time":"2009-07-26T06:08:04Z","timestamp":1248588484000},"page":"1803-1810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome"],"prefix":"10.1016","volume":"92","author":[{"given":"Jos\u00e9","family":"Bellver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pellicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.06.033_bib1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#","article-title":"Guidelines for referral and management of systemic lupus erythematosus in adults","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib2","first-page":"1351","article-title":"Systemic lupus erythematosus","volume":"76","author":"Madhok","year":"2007","journal-title":"Am Pham Physician"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-0897.2004.00165.x","article-title":"Undiagnosed systemic lupus erythematosus in a cohort of infertile women","volume":"51","author":"Geva","year":"2004","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/bmj.39358.519491.AD","article-title":"Systemic lupus erythematosus","volume":"335","author":"Mackillop","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00024677-200403010-00003","article-title":"Estrogen therapy in systemic lupus erythematosus","volume":"3","author":"Askanase","year":"2004","journal-title":"Treat Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","article-title":"The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial","volume":"142","author":"Buyon","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/art.1780180301","article-title":"Monozygotic twins discordant for systemic lupus erythematosus","volume":"18","author":"Yocum","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0889-857X(05)70137-X","article-title":"Genetics of systemic lupus erythematosus: clinical implications","volume":"26","author":"Sullivan","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1074-7613(01)00201-1","article-title":"Delineating the genetic basis of systemic lupus erythematosus","volume":"15","author":"Wakeland","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib11","series-title":"Systemic lupus erythematosus","first-page":"74","article-title":"The genetics of lupus","author":"Namjou","year":"2007"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib12","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1191\/0961203304lu2012oa","article-title":"Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide","volume":"13","author":"Katsifis","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib14","first-page":"S37","article-title":"The biological aspects of risks of infertility due to age: the female side","volume":"53","author":"Gougeon","year":"2005","journal-title":"Rev Epidemiol Sante Republique"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1191\/0961203304lu2029ed","article-title":"Ovarian failure and strategies for fertility preservation in patients with systemic lupus erythematosus","volume":"13","author":"Raptopoulou","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinte.160.5.610","article-title":"The effects of immunopressive and anti-inflammatory medications on fertility, pregnancy, and lactation","volume":"160","author":"Janssen","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120300678828596","article-title":"Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy","volume":"9","author":"Blumemfeld","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib18","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.21263","article-title":"Use of gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus","volume":"52","author":"Somers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MED.0b013e32831a46e9","article-title":"GnRH-agonists in fertility preservation","volume":"15","author":"Blumemfeld","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.hoc.2007.10.007","article-title":"The clinical spectrum of antiphospholipid syndrome","volume":"22","author":"Baker","year":"2008","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.disamonth.2003.10.001","article-title":"Antiphospholipid syndrome","volume":"49","author":"Gezer","year":"2003","journal-title":"Dis Mon"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1191\/0961203304lu2000oa","article-title":"Autoimmunity, infertility and assisted reproductive technologies","volume":"13","author":"Lockshin","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.semperi.2007.05.005","article-title":"The impact of autoimmune disorders and adverse pregnancy outcome","volume":"31","author":"Mecacci","year":"2007","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for international clinical studies including therapeutics","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib28","first-page":"45","article-title":"Induction d'ovulation et lupus","volume":"154","author":"Huong","year":"2003","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12016-007-0010-2","article-title":"Antiphospholipid antibodies and infertility","volume":"32","author":"Carp","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib30","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0015-0282(98)00312-4","article-title":"Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study","volume":"70","author":"Stern","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/dmn013","article-title":"Bidirectional effects on autoimmunity and reproduction","volume":"14","author":"Cervera","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/humrep\/dem383","article-title":"The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion","volume":"23","author":"Bellver","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0015-0282(99)00498-7","article-title":"Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis","volume":"73","author":"Horstein","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/1464727992000199731","article-title":"Antiphospholipid antibodies and infertility","volume":"5","author":"Backos","year":"2002","journal-title":"Hum Fertil"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib35","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.fertnstert.2006.08.044","article-title":"Anti-phospholipid antibodies do not affect IVF success","volume":"86","author":"The Practice Committee of the American Society for Reproductive Medicine","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/berh.2002.0225","article-title":"Reproductive health in SLE","volume":"16","author":"Askanase","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1472-6483(10)61009-7","article-title":"Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events","volume":"12","author":"Shulman","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib38","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/art.1780371109","article-title":"Systemic lupus erythematosus induced by ovulation induction treatment","volume":"37","author":"Ben-Chetrit","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib39","first-page":"1639","article-title":"Fatal exacerbation of systemic lupus erythematosus after induction of ovulation","volume":"24","author":"Casoli","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib40","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/rheumatology\/35.11.1184","article-title":"Risks of ovulation-induction therapy in systemic lupus erythematosus","volume":"35","author":"Huong","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.thromres.2007.05.023","article-title":"The \u201cART\u201d of thromboembolism: a review of assisted reproductive technology and thromboembolic complications","volume":"121","author":"Chan","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3346\/jkms.2002.17.4.574","article-title":"A case of cerebral infarct in combined antiphospholipid antibody and ovarian hyperstimulation syndrome","volume":"17","author":"Koo","year":"2002","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib43","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10067-006-0231-4","article-title":"Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation","volume":"26","author":"Giner","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/030097402320318468","article-title":"Intracardiac thrombosis and fever possibly triggered by ovulation induction in a patient with antiphospholipid syndrome","volume":"31","author":"Andrejevic","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11239-007-0009-9","article-title":"Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature","volume":"24","author":"Girolami","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/jaut.2000.0416","article-title":"Management of patients with antiphospholipid antibodies undergoing in vitro fertilization","volume":"15","author":"Udoff","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib47","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y","article-title":"Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome","volume":"43","author":"Guballa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/oxfordjournals.humrep.a137461","article-title":"Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state?","volume":"6","author":"Aune","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib49","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9378(81)90744-4","article-title":"Response of blood coagulation parameters to elevated endogenous 17\u03b2 estradiol levels induced by menopausal gonadotropins","volume":"140","author":"Kim","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib50","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/oxfordjournals.humrep.a137978","article-title":"Von Willebrand factor: an endothelial marker to monitor in vitro fertilization patients with ovarian hyperstimulation syndrome","volume":"8","author":"Todorow","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib51","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/art.1780400505","article-title":"Past use of oral contraceptives and the risk of developing systemic lupus erythematosus","volume":"40","author":"Sanchez-Guerrero","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib52","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780250603","article-title":"Influence of oral contraceptive therapy on activity of systemic lupus erythematosus","volume":"25","author":"Jungers","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib53","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib54","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"S\u00e1nchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib55","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0002-9378(12)91810-4","article-title":"Coagulation and anticoagulation effects of contraceptive steroids","volume":"170","author":"Samsioe","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2141.2007.06973.x","article-title":"Common risk factors for both arterial and venous thrombosis","volume":"140","author":"Lowe","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00006254-198507000-00003","article-title":"Effects of oral contraceptives on blood coagulation: a review","volume":"40","author":"Beller","year":"1985","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/sarh.2002.37212","article-title":"Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles","volume":"32","author":"Huong","year":"2002","journal-title":"Semin Artritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib59","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/humrep\/deh185","article-title":"Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial","volume":"19","author":"Ricci","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib60","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2007-0409","article-title":"Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction","volume":"92","author":"Alvarez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14647270601111239","article-title":"Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome","volume":"10","author":"Mathur","year":"2007","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib62","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/humrep\/deh638","article-title":"Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib63","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/art.10386","article-title":"Treatment with gonadotropins-releasing hormone agonists and prevention of multiple gestations in lupus or antiphospholipid syndrome patients undergoing in vitro fertilization: comment on the article by Guballa et al. [Letter]","volume":"46","author":"Blumemfeld","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/0891693031000067313","article-title":"Lupus pregnancy","volume":"36","author":"Lockshin","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib65","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/j.1552-4604.1995.tb04066.x","article-title":"Clinical pharmacology or estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women","volume":"35","author":"Schwartz","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib66","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1258\/175404507780796433","article-title":"Systemic lupus erythematosus and hormone replacement therapy","volume":"13","author":"Gompel","year":"2007","journal-title":"Menopause Int"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0301-2115(98)00312-1","article-title":"Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases","volume":"83","author":"Carmona","year":"1999","journal-title":"Eur J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/joneph\/16.2.161","article-title":"The risk of pregnancy in patients with lupus nephritis","volume":"16","author":"Moroni","year":"2003","journal-title":"J Nephrol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/joneph\/19.2.135","article-title":"Pregnancy in patients with kidney disease","volume":"19","author":"Stratta","year":"2006","journal-title":"J Nephrol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib70","first-page":"1333","article-title":"Antiphospholipid syndrome: obstetric diagnosis, management, and controversies","volume":"10","author":"Branch","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.06.033_bib71","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/bmj.332.7546.890","article-title":"Systemic lupus erythematosus","volume":"332","author":"D'Cruz","year":"2006","journal-title":"BMJ"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209013545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209013545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:30:43Z","timestamp":1777296643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209013545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0015028209013545"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.06.033","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}